Cargando…
Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial
BACKGROUND: A recent publication on efficacy of Sprifermin for knee osteoarthritis (OA) using quantitatively MRI-defined central medial tibio-femoral compartment cartilage thickness as the structural primary endpoint reported no statistically significant dose response. However, Sprifermin was associ...
Autores principales: | Roemer, Frank W., Aydemir, Aida, Lohmander, Stefan, Crema, Michel D., Marra, Monica Dias, Muurahainen, Norma, Felson, David T., Eckstein, Felix, Guermazi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938999/ https://www.ncbi.nlm.nih.gov/pubmed/27393009 http://dx.doi.org/10.1186/s12891-016-1128-2 |
Ejemplares similares
-
Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location‐Independent Post Hoc Analysis Using Magnetic Resonance Imaging
por: Eckstein, Felix, et al.
Publicado: (2015) -
Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial
por: Eckstein, Felix, et al.
Publicado: (2020) -
Efficacy and safety of sprifermin injection for knee osteoarthritis treatment: a meta-analysis
por: Zeng, Ni, et al.
Publicado: (2021) -
Sprifermin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-Related Diseases
por: Song, Zongmian, et al.
Publicado: (2021) -
Meniscal body extrusion and cartilage coverage in middle-aged and elderly without radiographic knee osteoarthritis
por: Svensson, Fredrik, et al.
Publicado: (2018)